Oncoinvent A

Oncoinvent A EBIT per Share

The EBIT per Share of Oncoinvent A (ONCIN.OL) as of Nov 7, 2026 is -1.62 NOK. In the previous year, EBIT per Share was -1.64 NOK — a change of -1.20% (higher).

EBIT per Share

-1.62NOK

YoY

-1.20%

Last updated:

EBIT per Share of Oncoinvent A is 2025 -1.62 NOK. EBIT per Share of Oncoinvent A was 2024 -1.64 NOK. It decreases by -1.20% higher compared to the previous year.

The Oncoinvent A EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2021
-3.22 NOK
Jan 1, 2022
-3.13 NOK
Jan 1, 2023
-1.96 NOK
Jan 1, 2024
-1.64 NOK
Jan 1, 2025
-1.62 NOK
Jan 1, 2026 (e)
-0.37 NOK
Jan 1, 2027 (e)
-0.19 NOK
Jan 1, 2028 (e)
-0.02 NOK
The Oncoinvent A EBIT per Share history
YEAREBIT per ShareYoY
est-0.02NOK-88.84%
est-0.19NOK-47.99%
est-0.37NOK-77.28%
-1.62NOK-1.20%
-1.64NOK-16.46%
-1.96NOK-37.24%
-3.13NOK-2.81%
-3.22NOK+704.65%
-0.40NOK-88.46%
-3.46NOK-4.64%
-3.63NOK-9.59%
-4.02NOK-5.08%
-4.23NOK+41.98%
-2.98NOK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Oncoinvent A Stock analysis

What does Oncoinvent A do? Oncoinvent ASA is a radiopharmaceutical company based in Oslo, Norway, operating within the Health Care sector. Listed on 13 December 2024, the firm employs 46 people and focuses on developing alpha-emitting radiotherapeutics for cancer patients. Its primary product, Radspherin, is an alpha-emitting radioactive microsphere therapy designed to treat metastatic cancers in body cavities. This suspension of calcium carbonate microspheres labelled with Radium-224 targets residual micro-metastases on intracavitary surfaces and in liquids after surgery, aiming to spare deeper organs from harmful radiation doses. Oncoinvent A is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Oncoinvent A stock

EBIT per Share of Oncoinvent A is -1.62 NOK in 2025.

EBIT per Share of Oncoinvent A changed from -1.64 NOK to -1.62 NOK, representing a -1.20% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Oncoinvent A since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Oncoinvent A

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Oncoinvent A